Aster Capital Management (Difc) LTD Context Therapeutics Inc. Transaction History
Aster Capital Management (Difc) LTD
- $262 Billion
- Q4 2024
A detailed history of Aster Capital Management (Difc) LTD transactions in Context Therapeutics Inc. stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 52,792 shares of CNTX stock, worth $35,370. This represents 0.02% of its overall portfolio holdings.
Number of Shares
52,792
Previous 52,792
-0.0%
Holding current value
$35,370
Previous $103 Million
46.43%
% of portfolio
0.02%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding CNTX
# of Institutions
55Shares Held
72.9MCall Options Held
0Put Options Held
0-
Bio Impact Capital LLC Cambridge, MA14.7MShares$9.85 Million2.18% of portfolio
-
Avidity Partners Management LP Dallas, TX7.48MShares$5.01 Million0.84% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.42MShares$4.97 Million0.32% of portfolio
-
Nextech Invest Ag7.42MShares$4.97 Million1.37% of portfolio
-
Blue Owl Capital Holdings LP New York, NY6.36MShares$4.26 Million2.69% of portfolio
About Context Therapeutics Inc.
- Ticker CNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,966,100
- Market Cap $10.7M
- Description
- Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therape...